Cargando…
Preparation and SPECT/CT Imaging of (177)Lu-Labeled Peptide Nucleic Acid (PNA) Targeting CITED1: Therapeutic Evaluation in Tumor-Bearing Nude Mice
PURPOSE: The expression of Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 (CITED1) is upregulated in papillary thyroid carcinoma (PTC) and mediates cell proliferation and migration. To facilitate early diagnosis and monitoring of recurrent or metastatic PTC, we desig...
Autores principales: | Li, Jia, Zhang, Lei, Li, Wenbo, Lei, Chengming, Cao, Yiyi, Wang, Ying, Wang, Zhengjie, Pang, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970276/ https://www.ncbi.nlm.nih.gov/pubmed/32021292 http://dx.doi.org/10.2147/OTT.S238098 |
Ejemplares similares
-
Comparative Evaluation of Novel (177)Lu-Labeled PNA Probes for Affibody-Mediated PNA-Based Pretargeting
por: Tano, Hanna, et al.
Publicado: (2021) -
The role of (18)F-FCH PET/CT in patients with uremic hyperparathyroidism compared with (99m)Tc-sestaMIBI SPECT/CT and ultrasonography
por: Xue, Yu, et al.
Publicado: (2019) -
Quantitative accuracy of (177)Lu SPECT imaging for molecular
radiotherapy
por: Mezzenga, Emilio, et al.
Publicado: (2017) -
Quantitative (177)Lu SPECT (QSPECT) imaging using a commercially available SPECT/CT system
por: Beauregard, Jean-Mathieu, et al.
Publicado: (2011) -
Accuracy of (177)Lu activity quantification in SPECT imaging: a phantom study
por: Uribe, Carlos F., et al.
Publicado: (2017)